• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

    31.82 +2.36 (+8.01%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,651,790
    Open 29.69
    Bid (Size) 27.80 (100)
    Ask (Size) 33.90 (100)
    Prev. Close 29.46
    Today's Range 29.27 - 31.83
    52wk Range 22.24 - 46.00
    Shares Outstanding 58,951,469
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss ↗
    Agios Pharmaceuticals (NASDAQ:AGIO) used an investor webcast tied to the 2026 European Hematology Association Congress in Stockholm to highlight new clinical data for mitapivat across thalassemia and... 
    Via MarketBeat
    News headline image
    Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
    From Avanzanite Bioscience B.V. and Agios Pharmaceuticals, Inc.
    Via Business Wire

    Performance

    YTD
    +17.1%
    +17.1%
    1 Month
    +12.8%
    +12.8%
    3 Month
    +10.3%
    +10.3%
    6 Month
    +18.5%
    +18.5%
    1 Year
    -11.0%
    -11.0%

    More News

    Read More
    News headline image
    Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances ↗
    Via MarketBeat
    Agios Pharmaceuticals (NASDAQ:AGIO) Q1 2026 Earnings Beat Drives Stock Rally ↗
    Via Chartmill
    Topics Earnings
    Agios Pharmaceuticals Inc (NASDAQ:AGIO) Reports Q4 2025 Revenue Beat and Narrower Loss ↗
    Via Chartmill
    News headline image
    Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) ↗
    Via The Motley Fool
    News headline image
    Agios (AGIO) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday ↗
    Via The Motley Fool
    News headline image
    Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) ↗
    Via The Motley Fool
    News headline image
    Agios (AGIO) Q3 2024 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Agios (AGIO) Q2 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Agios (AGIO) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Here's Why Agios Pharmaceuticals Crashed 23% Today ↗
    Via The Motley Fool
    What's going on in today's session ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Why Is Agios Pharmaceuticals Stock Surging Tuesday Afternoon? ↗
    Via Benzinga
    News headline image
    Why Agios Pharmaceuticals Stock Is Up More Than 21% Today ↗
    Via The Motley Fool
    News headline image
    Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
    Via The Motley Fool
    News headline image
    Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Agios (AGIO) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Retail’s Christmas Eve Watchlist: Omeros, Nike, Citi, Dynavax And Agios Spark Most Market Chatter ↗
    Via Stocktwits
    Topics ETFs Economy Stocks
    News headline image
    Here's Why Shares in Agios Pharmaceuticals Popped Today ↗
    Via The Motley Fool
    News headline image
    Which stocks are gapping on Wednesday? ↗
    Via Chartmill

    Frequently Asked Questions

    Is Agios Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Agios Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Agios Pharmaceuticals, Inc. - Common Stock trade on?
    Agios Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock is AGIO on the Nasdaq Stock Market
    What is the current price of Agios Pharmaceuticals, Inc. - Common Stock?
    The current price of Agios Pharmaceuticals, Inc. - Common Stock is 31.82
    When was Agios Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Agios Pharmaceuticals, Inc. - Common Stock was at 06/15/26 04:00 PM ET
    What is the market capitalization of Agios Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Agios Pharmaceuticals, Inc. - Common Stock is 1.88B
    How many shares of Agios Pharmaceuticals, Inc. - Common Stock are outstanding?
    Agios Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.